Article
The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).
Andrology - 1 Jul 2018
Chen Z P, Yan Y, Chen C J, Li M, Chen C, Zhao S C, Song T, Liu T, Zou C H, Xu Q, Li X
Abstract excerpt
Studies have shown that 48.59% of benign prostate hyperplasia (BPH) is combined with metabolic syndrome (MetS). The mainstream view supports the correlation between MetS and BPH, but the pathogenesis of MetS-BPH is not fully understood. Four hundred and seventy-four men, aged 47 years or older, were recruited into this study by consecutive routine physical examination programs, and several parameters were...
Topics
Join the communities discussing this publication.